Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-08-21

FDA Approved: ISOTRETINOIN — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

Supplemental application approval for isotretinoin from Zydus Pharmaceuticals USA Inc. (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ISOTRETINOIN (Isotretinoin)

Snippet

SUPPL AP for ISOTRETINOIN (ISOTRETINOIN)